Showing results (131-140 of 196) with videos related to

Sort By:
Pageof 20
Gut|January 17, 2013
Combination therapies with NS5A, NS3 and NS5B inhibitors on different genotypes of hepatitis C virus in human hepatocyte chimeric miceNiu Shi, Nobuhiko Hiraga, Michio Imamura, et al.
Journal of Viral Hepatitis|June 9, 2021
Serum PreS1 and HBsAg ratio reflects liver fibrosis and predicts the development of hepatocellular carcinoma in chronic hepatitis B patientsYuno Nishida, Michio Imamura, Yuji Teraoka, et al.
BMC Gastroenterology|August 1, 2021
Increasing incidence of non-HBV- and non-HCV-related hepatocellular carcinoma: single-institution 20-year studyYuko Nagaoki, Hideyuki Hyogo, Yuwa Ando, et al.
Bioorganic & Medicinal Chemistry Letters|August 16, 2012
β-D-2'-α-F-2'-β-C-Methyl-6-O-substituted 3',5'-cyclic phosphate nucleotide prodrugs as inhibitors of hepatitis C virus replication: a structure-activity relationship studyJinfa Du, Donghui Bao, Byoung-Kwon Chun, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 7, 2026
Efficacy and Safety of Second-Line Lenvatinib After First-Line Durvalumab Plus Tremelimumab in Unresectable Hepatocellular CarcinomaRyoichi Miura, Tomokazu Kawaoka, Saki Sueda, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|March 6, 2013
[A case of clonorchiasis complicated with the expansion of liver cyst]Yoko Kominami, Hiroshi Aikata, Ken Hiramatsu, et al.
Internal Medicine (Tokyo, Japan)|September 3, 2025
The Efficacy and Safety of Atezolizumab Plus Bevacizumab after Durvalumab Plus Tremelimumab for the Treatment of Hepatocellular CarcinomaShinsuke Uchikawa, Tomokazu Kawaoka, Aiko Tanaka, et al.
The Journal of General Virology|June 15, 2019
Efficacy of glecaprevir and pibrentasvir treatment for genotype 1b hepatitis C virus drug resistance-associated variants in humanized miceMitsutaka Osawa, Takuro Uchida, Michio Imamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 3, 2014
Interferon lambda 4 polymorphism affects on outcome of telaprevir, pegylated interferon and ribavirin combination therapy for chronic hepatitis CYuko Nagaoki, Michio Imamura, Yoshiiku Kawakami, et al.
Hepatology International|April 26, 2023
Serum interleukin-6 level predicts the prognosis for patients with alcohol-related acute-on-chronic liver failureSerami Murakami, Michio Imamura, Takuro Uchida, et al.
Pageof 20